CD5⁺ B Lymphocytes and CD4⁺CD45RA⁺T Cells in Graves' Disease

References

• Grubeck-Loebenstein B, Turner M, Pirich K, Kassal H, Londei M, Waldhäusl W, Feldmann M. CD4+ T-cell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production. Scand J Immunol 1990; 32: 433–440
   PubMed Web of Science ®Google Scholar
• Dayan C M., Londei M, Corcoran A E., Grubeck-Loebenstein B, James R FL, Rapoport B, Feldmann M. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA 1991; 88: 7415–7419
   PubMed Web of Science ®Google Scholar
• Casali P, Notkins A L. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10: 364–368
   PubMedGoogle Scholar
• Maini R N., Plater-Zyberk C, Andrew E. Autoimmunity in rheumatoid arthritis: An approach via a study of B lymphocytes. Rheum Dis Clin North Am 1987; 13: 319–338
   PubMed Web of Science ®Google Scholar
• Taniguchi O, Miyajima H, Hirano T, Noguchi M, Ueda A, Hashimoto H, Hirose S -I, Okumura K. The leu-1 B-cell subpopulation in patients with rheumatoid arthritis. J Clin Immunol 1987; 7: 441–448
   PubMed Web of Science ®Google Scholar
• Sowden J A, Robert-Thomson P J, Zola H. Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic disease. Rheum Int 1987; 7: 255–259
   Google Scholar
• Goto M, Miyamoto T, Nishioka K, Uchida S. T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids. Arthritis Rheum 1987; 30: 737–743
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Kingsley G, Murphy J, Panayi G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immun Immunopath 1987; 45: 252–258
   PubMedGoogle Scholar
• Emery P, Gentry K C., MacKay I R., Muirden K D., Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987; 30: 849–856
   PubMed Web of Science ®Google Scholar
• Lasky H P., Bauer K, Pope R M. Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. Arthritis Rheum 1988; 31: 52–59
   PubMed Web of Science ®Google Scholar
• Dauphinée M, Tovar Z, Talal N. B Cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum 1988; 31: 642–647
   PubMed Web of Science ®Google Scholar
• Afeltra A, Galeazzi M, Basso P, Pietrucci A, DePitá O, Ferri G M., Porzio F, Bonomo L J. Immune imbalance in the synovial fluid of rheumatoid arthritis patients: effects of intra-articular injection of thymopentin. J Biol Regul Homeost Agents 1991; 5: 71–75
   Google Scholar
• Volpè R, Karlsson A, Jansson R, Dahlberg P A. Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease. Acta Endocrinol(Copenh) suppl 1987; 281: 305–311
   Google Scholar
• Iitaka M, Aguayo J F., Iwatani Y, Row V V., Volpè R. Studies of the effect of suppressor T lymphocytes on the induction of antithyroid microsomal antibody-secreting cells in autoimmune thyroid disease. J Clin Endocrinol Metab 1988; 66: 708–714
   PubMed Web of Science ®Google Scholar
• Eguchi K, Ueki Y, Shimomura C, Otsubo T, Nakao H, Migita K, Kawakami A, Matsunaga M, Tezuka H, Ishikawa N, Ito K, Nagataki S. Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease. J Immunol 1989; 142: 4233–4240
   PubMedGoogle Scholar
• Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H., Matsunaga M, Kawabe Y, Shimomura C, Izumi M, Ban Y, Ito K, Nagataki S. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. J Clin Endocrinol Metab 1987; 65: 17–23
   PubMed Web of Science ®Google Scholar
• Wallace D L., Beverley P CL. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990; 69: 460–467
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Kingsley G, Haskard D, Panayi G. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988; 18: 1397–1404
   PubMed Web of Science ®Google Scholar
• Damle N K., Doyle L V. Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation. J Immunol 1990; 144: 1233–1240
   PubMed Web of Science ®Google Scholar
• Sato K, Miyasaka N, Yamaoka K, Okuda M, Yata J, Nishioka K. Quantitative defect of CD4+2H+ cells in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1987; 30: 1407–1411
   PubMed Web of Science ®Google Scholar
• Moore K, Walters M T., Jones D B., Garvey E, Harvey J, Cawley M ID, Smith J L. An immunological study of CD4+ lymphocyte subsets within inflammatory lesions with special reference to rheumatoid arthritis and inflammatory bowel disease. Immunology 1988; 65: 457–463
   PubMedGoogle Scholar
• Rose L M., Ginsberg A H., Rothstein T L., Ledbetter J A., Clark E A. Selective loss of a subset of T helper cells in active multiple sclerosis. Proc Natl Acad Sci USA 1985; 82: 7389–7393
   PubMed Web of Science ®Google Scholar
• Canonica G W., Bagnasco M, Corte G, Ferrini S, Ferrini O, Giordano G. Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells. Clin Immunol Immunopathol 1982; 23: 616–625
   Google Scholar
• Canonica G W., Bagnasco M, Cosulich M E., Torre G, McLachlan S M., Rees Smith B. Why thyroid is major site of thyroid autoantibody synthesis in autoimmune thyroid disease. Lancet 1983; 1: 1163
   Google Scholar
• Jackson R A., Haynes B F., Burch W M., Shimizu K, Bowring M A., Eisenbarth G S. Ia+ T cells in new onset Graves' disease. J Clin Endocrinol Metab 1984; 59: 187–190
   PubMed Web of Science ®Google Scholar
• Bonnyns M, Bentin J, Devetter G, Duchateau J. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status. Clin Exp Immunol 1983; 52: 629–634
   PubMed Web of Science ®Google Scholar
• Zeki K, Fujihira T, Shirakawa F, Watanabe K, Eto S. Existence and immunological significance of circulating Ia+ T cells in autoimmune thyroid diseases. Acta Endocrinol (Copenh) 1987; 115: 282–288
   PubMedGoogle Scholar
• Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. J Clin Endocrinol Metab 1986; 62: 723–728
   PubMed Web of Science ®Google Scholar
• Davies T F., Roman S H., MacKenzie W A., Goldsmith N, Dower S M., Piccinini L A. Thyroid cell MHC class II antigens: A perspective on the aetiology of autoimmune thyroid disease. Acta Endocrinol (Copenh) 1987; 281: 13–20, suppl.
   Google Scholar